BridgeMD
New treatment option for Erythromelalgia
Official title Spinal Cord Stimulation for Refractory Pain in Erythromelalgia
ClinicalTrials.gov ID: NCT04039633
What this study is testing
- What it's testing
- Erythromelalgia is a rare disorder characterized by red, warm, and painful extremities, which is often precipitated by warm conditions. The pathophysiology is incompletely understood.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- A diagnosis of primary or idiopathic erythromelalgia
- Patients ≥18 years who have developed chronic pain that has remained refractory to medical treatment for ≥6 months.
- Minimum pain intensity of 5/10 on a numeric rating scale NRS at baseline.
- Successful two-week SCS testing period with tonic stimulation (≥2 points reduction in pain NRS from baseline). This means patients will experience...
You likely can't join if
- Coexisting conditions that would increase procedural risk (e.g., sepsis, coagulopathy).
- History of laminectomy or posterior fusion at the thoracolumbar junction, where percutaneous electrode end tips are routinely placed.
- Abnormal pain behavior and/or unresolved psychiatric illness.
- Unresolved issues of secondary gain or inappropriate medication use.
- Unfit for participation for any other reason as judged by the study physician.
The study team makes the final eligibility decision.
Where it's taking place
- Halden, Norway
- Strømmen, Norway
- Tromsø, Norway
- Trondheim, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Halden, Norway; Strømmen, Norway; Tromsø, Norway; Trondheim, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.